Administration of LHRH agonist (43 vs. 60%, p = 0.04) and the number of lymph node metastasis (35 vs. 54%, p = 0.002) were greater in the NSAA than in the docetaxel group. Here, GNRH1 is linked to metastatic malignant neoplasm in the lymph nodes.